Rentabilidad en 3 años
| Fondo | Fecha | |||||
|---|---|---|---|---|---|---|
| 3 años | ||||||
| Resultados por página: 10 | 20 | 50 | 100Se muestran de 761 a 770 de un total de 43533 fondos | ||||||
| GOLDMAN SACHS JAPAN EQUITY PARTNERS PORTFOLIO I H GBP CAP | 29/10 | 108,55% | ||||
| MSIF US GROWTH I (EUR) | 29/10 | 108,53% | ||||
| FRANKLIN TECHNOLOGY N (ACC) EUR | 29/10 | 108,52% | ||||
| FRANKLIN TECHNOLOGY N (ACC) USD | 29/10 | 108,51% | ||||
| FRANKLIN BIOTECHNOLOGY DISCOVERY I (ACC) USD | 29/10 | 108,50% | ||||
| ALKEN FUND - CONTINENTAL EUROPE SGB1 | 29/10 | 108,46% | ||||
| POLAR CAPITAL BIOTECHNOLOGY R EUR DIS | 29/10 | 108,42% | ||||
| ALKEN FUND - EUROPEAN OPPORTUNITIES A | 29/10 | 108,41% | ||||
| MSIF US GROWTH I (USD) | 29/10 | 108,37% | ||||
| MSIF US GROWTH IX (USD) | 29/10 | 108,36% | ||||
